TD Private Client Wealth’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $603 | Sell |
36
-34
| -49% | -$570 | ﹤0.01% | 1339 |
|
|
2025
Q1 | $1.08K | Sell |
70
-8
| -10% | -$123 | ﹤0.01% | 1282 |
|
|
2024
Q4 | $1.72K | Buy |
78
+4
| +5% | +$88 | ﹤0.01% | 1208 |
|
|
2024
Q3 | $1.33K | Sell |
74
-93
| -56% | -$1.68K | ﹤0.01% | 1217 |
|
|
2024
Q2 | $2.71K | Buy |
167
+133
| +391% | +$2.16K | ﹤0.01% | 1121 |
|
|
2024
Q1 | $480 | Hold |
34
| – | – | ﹤0.01% | 1201 |
|
|
2023
Q4 | $355 | Buy |
+34
| New | +$355 | ﹤0.01% | 1206 |
|
|
2023
Q2 | – | Sell |
-27
| Closed | -$239 | – | 1282 |
|
|
2023
Q1 | $239 | Hold |
27
| – | – | ﹤0.01% | 1236 |
|
|
2022
Q4 | $246 | Hold |
27
| – | – | ﹤0.01% | 1202 |
|
|
2022
Q3 | $218 | Sell |
27
-11
| -29% | -$89 | ﹤0.01% | 1207 |
|
|
2022
Q2 | $286 | Hold |
38
| – | – | ﹤0.01% | 1214 |
|
|
2022
Q1 | $357 | Hold |
38
| – | – | ﹤0.01% | 1250 |
|
|
2021
Q4 | $304 | Sell |
38
-11,428
| -100% | -$91.4K | ﹤0.01% | 1151 |
|
|
2021
Q3 | $112K | Buy |
11,466
+11,428
| +30,074% | +$111K | ﹤0.01% | 616 |
|
|
2021
Q2 | $376 | Hold |
38
| – | – | ﹤0.01% | 1201 |
|
|
2021
Q1 | $439 | Hold |
38
| – | – | ﹤0.01% | 1135 |
|
|
2020
Q4 | $367 | Hold |
38
| – | – | ﹤0.01% | 1107 |
|
|
2020
Q3 | $342 | Buy |
38
+13
| +52% | +$117 | ﹤0.01% | 1068 |
|
|
2020
Q2 | $308 | Hold |
25
| – | – | ﹤0.01% | 1065 |
|
|
2020
Q1 | $225 | Buy |
+25
| New | +$225 | ﹤0.01% | 1041 |
|